Arcturus Therapeutics Holdings Inc.
ARCT · Pharmaceutical Preparations · 28.4M shares · +0%/yr ↑ dilution · EDGAR filings ↗
Reference price $16.56 · est. market cap ~$471M — last insider purchase, 2025-08-15 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D44Clinical/early-stage biotech — mRNA clinical, heavy burn, funded.
Strengths
- Liquidity — current ratio 6.6 (68th)
Risks
- Pre-revenue, deep losses — per metrics
- Pre-revenue/clinical-stage — history of losses & need for capital per risk factors
- Binary clinical & funding risk — per 10-K
Notable findings
- Cash burnNegative free cash flow (-74.5M)
- Net lossNet loss (net margin -80.2%)
- Exec changeRecent 8-K item 5.02 8-K ↗
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- Strong balance sheetStrong balance sheet — $231M cash & investments, ~12 quarters of runway
- Revenue declineRevenue -71.4% YoY
- Notable holderHeld by 6 notable fund(s): ARK Investment Management LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +3 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Operating margin
-93.0%
Net margin
-80.2%
Return on equity
-30.7%
Return on assets
-24.3%
Revenue growth (QoQ)
-71.4%
Current ratio
6.6×
Free cash flow
-$75M
EBITDA
-$73M
Tangible book value
$214M
Cash & investments
$231M
Cash runway
12q
Stock comp / revenue
31.0%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-08-15 | SASSINE ANDY | Buy | 1.2K | $16.56 |
| 2025-08-15 | SASSINE ANDY | Buy | 1.2K | $16.56 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
| Date | Items | |
|---|---|---|
| 2026-06-05 | Shareholder vote | filing ↗ |
| 2026-05-07 | ResultsExec/director changeReg FDExhibits | filing ↗ |
| 2026-03-03 | ResultsExhibits | filing ↗ |
| 2025-12-15 | Exec/director changeExhibits | filing ↗ |
| 2025-11-10 | ResultsExhibits | filing ↗ |
| 2025-10-22 | Reg FDOtherExhibits | filing ↗ |
| 2025-09-26 | Reg FDExhibits | filing ↗ |
| 2025-08-29 | Reg FDExhibits | filing ↗ |
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-05 | 2026-06-05 | 0001193805-26-000770 ↗ |
| 10-Q | 2026-05-07 | 2026-03-31 | 0001193125-26-211943 ↗ |
| 8-K | 2026-05-07 | 2026-05-01 | 0001193805-26-000573 ↗ |
| 10-K | 2026-03-03 | 2025-12-31 | 0001193125-26-088391 ↗ |
| 8-K | 2026-03-03 | 2026-03-03 | 0001193805-26-000214 ↗ |
| 8-K | 2025-12-15 | 2025-12-11 | 0001193805-25-001734 ↗ |
| 10-Q | 2025-11-12 | 2025-09-30 | 0001193125-25-275758 ↗ |
| 8-K | 2025-11-10 | 2025-11-10 | 0001193805-25-001555 ↗ |
| 8-K | 2025-10-22 | 2025-10-22 | 0001193805-25-001499 ↗ |
| 8-K | 2025-09-26 | 2025-09-26 | 0001193805-25-001368 ↗ |
| 8-K | 2025-08-29 | 2025-08-29 | 0001193805-25-001247 ↗ |
| 10-Q | 2025-08-11 | 2025-06-30 | 0000950170-25-106560 ↗ |